Seeking Alpha has a superb busineness analysis of the whole BMS/Plavix mess.
Of note:
"On August 8, 2006, after a patent dispute resolution failed to receive required antitrust clearance from New York state attorneys general, Canadian drug maker Apotex launched a generic copy of the blood-thinning treatment, clopidogrel (PLAVIX), even though it's being sued for patent infringement by Bristol-Myers, which holds the U.S. marketing rights to the Sanofi-Aventis (SNY) drug.
Bristol’s original patent suit claimed that Apotex infringed on a second patent (US. 4,847,265) covering a chiral compound, that purports to show that the “pharmacologically superior and less toxic” (+) enantiomer of clopidogrel is necessary for the efficacy/safety profile of PLAVIX" [and this patent does not expire until 2011]."
So we can see BMS/Sanofi's evergreening strategy here!
Insider's view: a great analysis. Insider has found a new fave blog! Also thanks to http://www.10qdetective.blogspot.com/
3 comments:
I think every medicine is toxic more or less. It cures but it's toxic as well.
After spending more than fifteen hours doing the background research to write the Plavix-BMY story, I took umbrage when I found out through a regular reader that you ERRONEOUSLY credited SeekingAlpha for this aforementioned posting:
" Seeking Alpha has a superb busineness analysis of the whole BMS/Plavix mess."
I am a contributing analyst who provides CONTENT to several blogging-ggregators, including SeekingAlpha--but the CONTENT is proprietary to www.10qdetective.blogspot.com
Thank You-
David J. Phillips, Publisher
www.10qdetective.blogspot.com
I'm sorry David, if I've offended you in any way.
Unintentional.
My piece actually says at the begining:
"Seeking Alpha has a superb busineness analysis of the whole BMS/Plavix mess."
And then at the end it says:
"Insider's view: a great analysis. Insider has found a new fave blog! Also thanks to http://www.10qdetective.blogspot.com/"
To me, that seems quite fair as I refer both to where I found it and who wrote it.
It is a great piece of work - well worth the time you spent on it.
Cheers
Jack
ps I did also try and respond to your email.....but it bounced back
Post a Comment